CDKN1A and colonic neoplasm: The silencing of CCAT1 in colon cancer cells reduces proliferation through CDKN1A/p21-mediated cell-cycle arrest in G1 phase and the injection of CCAT1 KD tumor cells delays tumorigenesis in xenograft models [148].